Continuing the Alzheimer’s and Neurodegenerative Diseases track in the Rejuvenation Biotechnology Conference, Jane Lebkowski, President of R&D, Asterias Biotherapeutics Inc. discussed her group’s work on the development of pluripotent stem cell derived oligodendrocyte progenitor cells for the treatment of spinal …